JPRN-jRCT2080223799已完成3 期
ong Term Follow-up Study to Evaluate the Safety of Repeated Intra-Articular Injection of SI-613 in Patients with Osteoarthritis(Japan. Phase III)
SEIKAGAKU CORPORATIO0 个研究点目标入组 160 人开始时间: 2018年2月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subject who has diagnosed with OA by X-ray and observed a deformability change at the time of screening.
- •Subject who has OA pain in the target joint which is longer than or equal to 12 weeks prior to the time of informed consent.
排除标准
- •Subjects who has significant joint deformation such as a large osteophyte or remarkable narrowing of the joint space.
- •Subject who is difficult to continue outpatient during informed concent and 52week.
研究者
相似试验
进行中（未招募）
1 期
A clinical study to learn about the effects of a virus that transfers the gene for human coagulation factor IX in adults with moderate/severe to severe inherited coagulations defects in the long termModerate/severe to severe hemophilia BMedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850EUCTR2016-003430-25-GBltragenyx Pharmaceutical, Inc.6
进行中（未招募）
1 期
A clinical study to learn about the effects of a virus that transfers the gene for Glucose- 6-Phosphatase (G6Pase) in adults with Glycogen Storage Disease Type IaEUCTR2018-004473-27-ESltragenyx Pharmaceutical Inc.12
进行中（未招募）
1 期
A clinical study to learn about the effects of a virus that transfers the gene for Glucose- 6-Phosphatase (G6Pase) in adults with Glycogen Storage Disease Type IaCTIS2023-504004-29-00ltragenyx Pharmaceutical Inc.12
进行中（未招募）
1 期
A clinical study to learn about the effects of a virus that transfers the gene for human Ornithine Transcarbamylase (OTC) in adults with late-onset OTC deficiency in the long termOrnithine transcarbamylase deficiencyEUCTR2018-000156-18-FRltragenyx Pharmaceutical, Inc.18
进行中（未招募）
1 期
A clinical study to learn about the effects of a virus that transfers the gene for human Ornithine Transcarbamylase (OTC) in adults with late-onset OTC deficiency in the long termOrnithine transcarbamylase deficiencyMedDRA version: 20.0Level: LLTClassification code: 10071107Term: Ornithine transcarbamylase deficiency Class: 10010331CTIS2022-501146-30-00ltragenyx Pharmaceutical Inc.11